Do you work in the cell therapy❓- 𝗧𝗼𝗱𝗮𝘆 𝗶𝘀 𝘆𝗼𝘂𝗿 𝗙𝗜𝗡𝗔𝗟 𝗖𝗛𝗔𝗡𝗖𝗘 to 𝘀𝗲𝗰𝘂𝗿𝗲 𝗼𝘂𝗿 𝗵𝗶𝗴𝗵𝗲𝘀𝘁 𝗱𝗶𝘀𝗰𝗼𝘂𝗻𝘁𝘀 𝗼𝗳 𝘂𝗽 𝘁𝗼 $𝟭,𝟭𝟬𝟬 - https://ter.li/t2kq70 for the 𝟲𝘁𝗵 𝗠𝗮𝗰𝗿𝗼𝗽𝗵𝗮𝗴𝗲-𝗗𝗶𝗿𝗲𝗰𝘁𝗲𝗱 𝗧𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝗦𝘂𝗺𝗺𝗶𝘁! This is a once-a-year opportunity to 𝗰𝗼𝗻𝗻𝗲𝗰𝘁 𝘄𝗶𝘁𝗵 𝗸𝗲𝘆 𝗽𝗹𝗮𝘆𝗲𝗿𝘀 from Carisma Therapeutics, ALX Oncology, NextPoint Therapeutics, Inc., Elpiscience Biopharmaceuticals, and more to unleash the full potential of your macrophage therapeutics and stay ahead of the curve.🤝 We also offer 𝗮𝗱𝗱𝗶𝘁𝗶𝗼𝗻𝗮𝗹 𝗴𝗿𝗼𝘂𝗽 𝗱𝗶𝘀𝗰𝗼𝘂𝗻𝘁𝘀 𝗼𝗳 𝘂𝗽 𝘁𝗼 𝟮𝟬%, which you can explore in our full agenda - https://ter.li/9vo845 Don't let this valuable opportunity slip away! 𝗕𝗼𝗼𝗸 𝗯𝗲𝗳𝗼𝗿𝗲 𝗺𝗶𝗱𝗻𝗶𝗴𝗵𝘁 𝘁𝗼 𝘀𝗮𝘃𝗲 $𝟭,𝟭𝟬𝟬, and make a real impact this year at the #MacrophageDirectedTherapiesSummit
Hanson Wade’s Post
More Relevant Posts
-
Tasca Therapeutics Launches with $52m Series A Financing to Develop Small Molecule Inhibitors for Multiple Oncology Indications https://lnkd.in/e5MHpMap Tasca Therapeutics Regeneron Ventures Cure Ventures The Invus Group Praveen Tipirneni milenko cicmil David Fallace More US life science business news at [LSUS] Life-Sciences-USA.com __
To view or add a comment, sign in
-
Thoughts on this? >> Aura's infrared light-activated drug stops tumor growth and preserves vision in eight eye cancer patients >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #biotech #productmarketing #healthcare #pharmaceutical
To view or add a comment, sign in
-
The antibody–drug conjugate (ADC) landscape is rapidly evolving and has become a significant therapeutic modality in oncology. The publication offers a nice overview of the ADC landscape. https://lnkd.in/eSGNKSEB
The antibody–drug conjugate landscape
nature.com
To view or add a comment, sign in
-
Thoughts on this? >> Adaptimmune gets FDA accelerated approval for T cell receptor cell therapy in rare soft tissue cancer >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #biotech #productmarketing #pharmaceutical #healthcare
Adaptimmune gets FDA accelerated approval for T cell receptor cell therapy in rare soft tissue cancer
endpts.com
To view or add a comment, sign in
-
Next-Gen ADCs Driving ‘Renaissance’ in Already Hot Oncology Drug Class. ADC Therapeutics, Sutro Biopharma, Inc. and Zailab are among those developing antibody-drug conjugates to address payload and toxicity challenges of current ADCs—and rapidly grow the multi-billion-dollar market... Check out the full story 👉 https://zurl.co/kgfp (BioSpace) #oncology #therapeutics
To view or add a comment, sign in
-
https://lnkd.in/gZEzac6Z Key Insights: • Astellas’ acquisition of Propella brings in PRL-02, a groundbreaking androgen biosynthesis inhibitor. This next-gen treatment holds promise in transforming prostate cancer therapy by offering continuous release of abiraterone, aiming for superior efficacy Visit MedicoInsights to explore key insights #HealthcareNews #drugs #StayInformed #MedicalNews #acquisitions #HealthTrends #Insights #HealthIndustry #HealthInnovation #astellas #acquire #propellatherapeutics #HealthcareAnalytics #NewsUpdate #HealthcareNetworking #pharma #pharmaceuticals #pharmanews #pharmaindustry #pharmainnovation #update #medicoinsights
Astellas Completes Acquisition of Propella Therapeutics
https://medicoinsights.com
To view or add a comment, sign in
-
Thoughts on this? >> Adaptimmune gets FDA accelerated approval for T cell receptor cell therapy in rare soft tissue cancer >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #biotech #productmarketing #pharma #pharmaceutical
Adaptimmune gets FDA accelerated approval for T cell receptor cell therapy in rare soft tissue cancer
endpts.com
To view or add a comment, sign in
-
Thoughts on this? >> Merck, Daiichi Sankyo detail Phase 2 ADC results in small cell lung cancer, bispecific combo strategy >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #healthcare #pharmaceutical #biotech #productmarketing
Merck, Daiichi detail Phase 2 ADC results in small cell lung cancer, bispecific combo strategy
endpts.com
To view or add a comment, sign in
-
Thoughts on this? >> Relay Therapeutics reports positive PFS data for its PI3Kα inhibitor combo in breast cancer >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #healthcare #biotech #productmarketing
Relay Therapeutics reports positive PFS data for its PI3Kα inhibitor combo in breast cancer
endpts.com
To view or add a comment, sign in
-
Thoughts on this? >> Relay Therapeutics reports positive PFS data for its PI3Kα inhibitor combo in breast cancer >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #biotech #healthcare #pharma #pharmaceutical
Relay Therapeutics reports positive PFS data for its PI3Kα inhibitor combo in breast cancer
endpts.com
To view or add a comment, sign in
17,772 followers